ADRs Advance; Innate Pharma S.A. Climbs 30%

Dow Jones
Nov 11

This article was automatically generated by Dow Jones using technology from Automated Insights.

International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American depositary receipts increased 1.6% to 231.45.

The European index increased 1.4% to 202.63. The Asian index added 1.8% to 311.52. The Latin American index gained 0.8% to 235.78, while the emerging-markets index rose 2.1% to 525.67.

France's Innate Pharma S.A. was the biggest leader during the session, rocketing 30% to $2.30, and Singapore-based Trident Digital Tech Holdings Ltd. jumped 18% to 70 cents. XPeng Inc., which is based in China, rounded out the top three leaders on Monday, with shares jumping 16% to $26.04.

Zepp Health Corp., based in China, posted the largest decline, plunging 18% to $22.40, followed by shares of United Kingdom's Barinthus Biotherapeutics PLC, which tumbled 18% to 88 cents. Shares of United Kingdom-based Wing Yip Food Holdings Group Ltd. plunged 10% to 91 cents.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 10, 2025 16:30 ET (21:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10